Kymera Therapeutics, Inc.(KYMR)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
KYMR is scheduled to report on Oct 29, 2026, usually before the market opens. Analysts expect EPS of -$1.29.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±3.9%).
Did the stock rise after good news?
The next-day move after each of its last 6 EPS beats and 4 misses.
In plain words: it beat expectations 6 times, but the stock still fell 3 of those 6 times.
- Aug '26Beat▲ +1.0%
- Apr '26Beat▼ -0.5%
- Feb '26Missed▲ +4.8%
- Nov '25Missed▲ +0.3%
- Aug '25Missed▼ -7.2%
- Feb '25Missed▼ -14.5%
- Oct '24Beat▼ -3.1%
- Aug '24Beat▼ -2.7%
- May '24Beat▲ +0.2%
- Feb '24Beat▲ +4.7%
Clear beats and misses with a known reaction only. What counts as a beat
Why did KYMR fall after beating earnings?
5 of KYMR's last 10 reactions went against the EPS result. What stands out in each:
KYMR beat EPS estimates in 6 quarters, and the stock still closed lower the next day 3 times. In 2 of the 3 where we have price data, the stock had already run up before the report.
- Apr 30, 2026EPS beat +17.4%stock -0.5% next day
- It opened 4.8% higher, but sellers took over and it closed -0.5%.
- Oct 31, 2024EPS beat +2.4%stock -3.1% next day
- It had risen 5.9% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 6.1% lower as soon as trading resumed.
- Aug 7, 2024EPS beat +12.1%stock -2.7% next day
- It had risen 5.0% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 9.8% higher, but sellers took over and it closed -2.7%.
Rose despite an EPS miss (2 of 4)
- Feb 26, 2026EPS missed -27.3%stock +4.8% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
- Nov 4, 2025EPS missed -20.5%stock +0.3% next day
Nothing in the price and estimate numbers we track stands out for this one. Guidance and management comments are not part of our data.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was KYMR's earnings move already priced in?
KYMR's move in the month before each of its last 10 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 10 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does KYMR hold its opening gap after earnings?
KYMR's opening move after each report and where it closed that day.
In 8 reports KYMR opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 8 times (50%), and fully reversed 4 times. Gaps up faded 2 of 3; gaps down recovered 2 of 5.
- Apr 30, 2026ReversedOpened +4.8%, closed -0.5%
- Feb 26, 2026ReversedOpened -5.2%, closed +4.8%
- Nov 4, 2025ReversedOpened -6.6%, closed +0.3%
- Aug 11, 2025HeldOpened -6.1%, closed -7.2%
- Feb 27, 2025HeldOpened -3.8%, closed -14.5%
- Oct 31, 2024HeldOpened -6.1%, closed -3.1%
- Aug 7, 2024ReversedOpened +9.8%, closed -2.7%
- Feb 22, 2024HeldOpened +2.9%, closed +4.7%
What the history says
- It fell after 3 of its 6 EPS beats (50%): beating estimates has not been enough on its own.
KYMR earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | Before open | -$0.74 | -$0.62 | +16.2% | +1.04% | +3.00% |
| Apr 30, 2026 | Before open | -$0.86 | -$0.71 | +17.4% | -0.54% | +2.55% |
| Feb 26, 2026 | Before open | -$0.77 | -$0.98 | -27.3% | +4.80% | -0.64% |
| Nov 4, 2025 | Before open | -$0.78 | -$0.94 | -20.5% | +0.32% | +2.14% |
| Aug 11, 2025 | Before open | -$0.80 | -$0.95 | -18.8% | -7.24% | +0.27% |
| May 9, 2025 | Before open | -$0.91 | -$0.82 | +9.9% | — | — |
| Feb 27, 2025 | Before open | -$0.79 | -$0.89 | -12.7% | -14.45% | -14.68% |
| Oct 31, 2024 | Before open | -$0.84 | -$0.82 | +2.4% | -3.15% | -1.26% |
| Aug 7, 2024 | Before open | -$0.66 | -$0.58 | +12.1% | -2.68% | +0.05% |
| May 2, 2024 | Before open | -$0.72 | -$0.62 | +13.9% | +0.17% | +5.68% |
| Feb 22, 2024 | Before open | -$0.38 | -$0.25 | +34.2% | +4.71% | +12.34% |
| Nov 2, 2023 | Before open | -$0.70 | -$0.90 | -28.6% | — | — |
Consensus for the next report: EPS -$1.29, revenue $3.11M.
KYMR Earnings FAQ
Answers computed from Kymera Therapeutics, Inc.'s reported history
KYMR is scheduled to report on Oct 29, 2026, usually before the market opens. Analysts expect EPS of -$1.29.
Over the last 12 quarters with a usable EPS surprise, KYMR beat the consensus estimate 7 times (58%), missed 5 and landed in line 0. It has beaten estimates in each of the last 2 counted quarters.
Across its last 10 quarters with a measured reaction, KYMR moved an average of ±3.9% in the first session after reporting. It closed higher 50% of the time; the largest gain was 4.8% and the largest drop -14.5%.
KYMR fell in the first session after 3 of its last 6 EPS beats (50%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 2 of the 3 of those falls where price data is available, the stock had already risen before the report.
Across its last 10 quarters with price data, KYMR moved an average of +2.5% in the 20 trading sessions before reporting and was higher in 50% of them. After a run-up of 3% or more (5 quarters), it fell the next day 40% of the time, averaging +0.8%. After a drop of 3% or more (3 quarters), it rose the next day 33% of the time, averaging -6.9%. This describes past reports; it is not a forecast.
In 8 reports KYMR opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 8 times (50%), and fully reversed 4 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · KYMR: 12 reported quarters, latest Aug 5, 2026. Information only, not investment advice.
Looking for more on KYMR?
Price charts, forecast, fundamentals and risk pages for KYMR are not on Tickzen yet. You can run a full stock analysis now.
Run the KYMR Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun